Maxim Group lowered shares of ABVC BioPharma (OTCMKTS:ABVC – Get Rating) from a buy rating to a hold rating in a research note published on Wednesday, The Fly reports. ABVC BioPharma Stock Performance OTCMKTS ABVC opened at $0.74 on Wednesday. The stock’s fifty day moving average is $0.80 and its two-hundred day moving average is […]
FREMONT, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) via NewMediaWire - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology
FREMONT, CA, June 21, 2022 via NewMediaWire – ABVC Biopharma, Inc. , a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and. | June 21, 2022
BATM Advanced Communications (LON:BVC – Get Rating)‘s stock had its “house stock” rating restated by research analysts at Shore Capital in a research report issued on Friday, MarketBeat reports. BVC opened at GBX 51.40 ($0.67) on Friday. The business has a fifty day moving average of GBX 55.79 and a 200 day moving average of […]
Squarepoint Ops LLC purchased a new stake in shares of ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 19,207 shares of the company’s stock, valued at approximately $44,000. Squarepoint Ops LLC owned approximately […]